It is currently estimated that more than 400,000 Americans and 2.5 million people worldwide are living with MS. In order for MS patients to continue receiving the best care for generations to come, it is imperative that the workforce of MS healthcare professionals be large enough to meet the growing demands.
The CMSC has focused on aggressively recruiting and training the community of dedicated specialists in the field. Our goal is to encourage medical students and other healthcare professionals to choose MS as an initial focus of study or to pursue more advanced and specialized training as part of their studies. Recipients are able to apply new skills and share knowledge with colleagues within their academic institution and practice settings.
By increasing the number of well-trained healthcare professionals in MS, and ensuring that they are well-trained and well-prepared, we can continue to deliver the finest care, improve the quality of life for patients and families living with MS, and ultimately find a cure.
For the CMSC to continue providing comprehensive care and specialized services to MS patients, it is paramount that the community of MS professionals has access to specialized training.
The Foundation of the CMSC funds scholarships for:
- Neurology residents;
- Research Scholarships for medical students.
Recipients of Neurology Resident annual meeting scientific scholarships are able to apply new skills and share knowledge with colleagues within their academic institutions and practice settings.
FCMSC Medical Student Research Scholars and Mentors
One of the most promising ways to build a committed and competent MS Workforce of the Future is to expose students to new challenges under the mentorship of top-tier experts. The MS Summer Research Scholar program pairs medical students with an impressive group of leading MS research and clinical experts for two-month projects covering a wide spectrum of MS research. Click here to read personal feedback from FCMSC Research Scholars and their mentors.
These students are invited to present the results of their work at the following year’s CMSC annual scientific meeting, encouraging a new pool of passionate MS professionals.
|FCMSC Medical Student Research Scholarship Presenters Annual Meeting 2019|
|Scholar||Research Project||Research Institution|
|Predictors of Intrathecal Baclofen Therapy Outcomes in Multiple Sclerosis Patients||Mellen Center for MS Treatment & Research/ Cleveland Clinic Foundation|
|Lymphopenia Risk and Lymphocyte Subset Alterations in Multiple Sclerosis Patients Treated with Ocrelizumab: A Preliminary Report||The University of Cincinnati and The Waddell Center for Multiple Sclerosis|
|Multi-Class Segmentation of Multiple Sclerosis Lesions using Confolutional Neural Networking in the Combirx Cohort||MRI Analysis Center, McGovern Medical School at UT Health|
|Initiation of Higher-Efficacy Disease-Modifying Therapy and Depressive Symptom Evolution in Patients with Multiple Sclerosis||Johns Hopkins University School of Medicine|
|Tracking Scanning Laser Opthalmoscope as a Prognostic and Monitoring Tool in Multiple Sclerosis||University of California, San Francisco, Multiple Sclerosis Center|
|Magnetic Resonance Imaging and Clinical Findings in Health, Genetically Characterized, Asymptomatic First-Degree Relatives in Multiple Sclerosis Patients and Health Controls||National Institutes of Neurological Disorders and Stroke|
|Biosensor Detection of Upper Limb Dysfunction in Multiple Sclerosis||University of California, San Francisco|
|Sexually Dimorphic Multiple Sclerosis Pathogenesis||Emory University School of Medicine|
|Magnetization Transfer Saturation Reveals Subclinical Optic Nerve Demyelination in Pediatric Multiple Sclerosis||SickKids Research Institute|
|Eye-Tracking in Pediatric Multiple Sclerosis||University of California-San Francisco Pediatric Multiple Sclerosis Center|
|Comparison of White Matter Lesion Burden Identified on 3T and 7T MRI in Pediatric-onset Multiple Sclerosis: Preliminary Findings||Children’s Hospital of Philadelphia|
|Course of Clinical Multiple Sclerosis in Children with the Radiologically Isolated Syndrome||Yale School of Medicine|
The Foundation of the CMSC salutes the supporters of MS Workforce of the Future initiatives:
- AbbVie, Inc.
- Bayer HealthCare Pharmaceuticals, Inc.
- Celgene Corporation
- EMD Serono, Inc.
- Inserra Family
- Mallinckrodt Pharmaceuticals
- Novartis Pharmaceuticals
- Sanofi Genzyme
With your help and support of the Foundation of the CMSC, we can ensure that future generations of people with MS will receive the quality healthcare they need and deserve.